A citation-based method for searching scientific literature

Cédric Moro, Michel Berlan. Fundam Clin Pharmacol 2006
Times Cited: 17







List of co-cited articles
50 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue.
R Sarzani, V M Paci, C M Zingaretti, C Pierleoni, S Cinti, G Cola, A Rappelli, P Dessì-Fulgheri. J Hypertens 1995
85
23

Expression of natriuretic peptide receptors in human adipose and other tissues.
R Sarzani, P Dessì-Fulgheri, V M Paci, E Espinosa, A Rappelli. J Endocrinol Invest 1996
192
17

Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals.
Thomas J Wang, Martin G Larson, Michelle J Keyes, Daniel Levy, Emelia J Benjamin, Ramachandran S Vasan. Circulation 2007
161
17

Natriuretic peptides: a new lipolytic pathway in human adipocytes.
C Sengenès, M Berlan, I De Glisezinski, M Lafontan, J Galitzky. FASEB J 2000
336
17

Impact of obesity on plasma natriuretic peptide levels.
Thomas J Wang, Martin G Larson, Daniel Levy, Emelia J Benjamin, Eric P Leip, Peter W F Wilson, Ramachandran S Vasan. Circulation 2004
705
17

Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients.
P Dessì-Fulgheri, R Sarzani, P Tamburrini, A Moraca, E Espinosa, G Cola, L Giantomassi, A Rappelli. J Hypertens 1997
161
17

Natriuretic peptides.
E R Levin, D G Gardner, W K Samson. N Engl J Med 1998
17

B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures.
Jennifer A Taylor, Robert H Christenson, Krishnamurti Rao, Melinda Jorge, Stephen S Gottlieb. Am Heart J 2006
114
11


N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.
Michael H Olsen, Tine W Hansen, Marina K Christensen, Finn Gustafsson, Susanne Rasmussen, Kristian Wachtell, Knut Borch-Johnsen, Hans Ibsen, Torben Jørgensen, Per Hildebrandt. Hypertension 2005
131
11

Comparative analysis of atrial natriuretic peptide receptor expression in rat tissues.
R Sarzani, V M Paci, P Dessì-Fulgheri, E Espinosa, A Rappelli. J Hypertens Suppl 1993
44
11

B-type natriuretic peptide levels in obese patients with advanced heart failure.
Tamara B Horwich, Michele A Hamilton, Gregg C Fonarow. J Am Coll Cardiol 2006
177
11

Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women.
C Sengenes, V Stich, M Berlan, J Hejnova, M Lafontan, Z Pariskova, J Galitzky. Int J Obes Relat Metab Disord 2002
68
11

Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
Daniel G Krauser, Donald M Lloyd-Jones, Claudia U Chae, Renee Cameron, Saif Anwaruddin, Aaron L Baggish, Annabel Chen, Roderick Tung, James L Januzzi. Am Heart J 2005
178
11

Relationship between obesity and B-type natriuretic peptide levels.
James McCord, Brian J Mundy, Michael P Hudson, Alan S Maisel, Judd E Hollander, William T Abraham, Philip G Steg, Torbjørn Omland, Cathrine W Knudsen, Keisha R Sandberg,[...]. Arch Intern Med 2004
119
11

An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans.
Max Lafontan, Cédric Moro, Coralie Sengenes, Jean Galitzky, François Crampes, Michel Berlan. Arterioscler Thromb Vasc Biol 2005
77
11

Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.
Sandeep R Das, Mark H Drazner, Daniel L Dries, Gloria L Vega, Harold G Stanek, Shuaib M Abdullah, Russell M Canham, Anne K Chung, David Leonard, Frank H Wians,[...]. Circulation 2005
299
11

Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity.
Coralie Sengenès, Alexia Zakaroff-Girard, Agnès Moulin, Michel Berlan, Anne Bouloumié, Max Lafontan, Jean Galitzky. Am J Physiol Regul Integr Comp Physiol 2002
120
11

Obese subjects with heart failure have lower N-terminal pro-brain natriuretic peptide plasma levels irrespective of aetiology.
Miguel Rivera, Raquel Cortés, Antonio Salvador, Vicente Bertomeu, Fernando García de Burgos, Rafael Payá, Manuel Portolés, Raquel Taléns-Visconti, Luis Martinez-Dolz, Ricardo Valero,[...]. Eur J Heart Fail 2005
37
11

Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue.
C Moro, E Klimcakova, K Lolmède, M Berlan, M Lafontan, V Stich, A Bouloumié, J Galitzky, P Arner, D Langin. Diabetologia 2007
91
11

Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.
Antoni Bayes-Genis, Donald M Lloyd-Jones, Roland R J van Kimmenade, John G Lainchbury, A Mark Richards, Jordi Ordoñez-Llanos, Miquel Santaló, Yigal M Pinto, James L Januzzi. Arch Intern Med 2007
99
11


Obesity and suppressed B-type natriuretic peptide levels in heart failure.
Mandeep R Mehra, Patricia A Uber, Myung H Park, Robert L Scott, Hector O Ventura, Bobbett C Harris, Edward D Frohlich. J Am Coll Cardiol 2004
344
11

A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives.
R Sarzani, P Dessì-Fulgheri, F Salvi, M Serenelli, D Spagnolo, G Cola, M Pupita, L Giantomassi, A Rappelli. J Hypertens 1999
69
11

Fatty acid mobilization from adipose tissue during exercise.
Jeffrey F Horowitz. Trends Endocrinol Metab 2003
116
11

Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions.
Lincoln R Potter, Sarah Abbey-Hosch, Deborah M Dickey. Endocr Rev 2006
700
11

Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass.
Speranza Rubattu, Sebastiano Sciarretta, Giuseppino Massimo Ciavarella, Vanessa Venturelli, Paola De Paolis, Giuliano Tocci, Luciano De Biase, Andrea Ferrucci, Massimo Volpe. J Hypertens 2007
32
11

Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension.
Carine M Boustany, Kalyani Bharadwaj, Alan Daugherty, David R Brown, David C Randall, Lisa A Cassis. Am J Physiol Regul Integr Comp Physiol 2004
242
11

Effects of body mass index and age on N-terminal pro brain natriuretic peptide are associated with glomerular filtration rate in chronic heart failure patients.
Morten Schou, Finn Gustafsson, Caroline N Kistorp, Pernille Corell, Andreas Kjaer, Per R Hildebrandt. Clin Chem 2007
25
11

N-terminal pro-B-type natriuretic peptide as an indicator of possible cardiovascular disease in severely obese individuals: comparison with patients in different stages of heart failure.
Katharina-Maria Hermann-Arnhof, Ursula Hanusch-Enserer, Thomas Kaestenbauer, Thomas Publig, Attila Dunky, Harald R Rosen, Rudolf Prager, Ursula Köller. Clin Chem 2005
23
11


Effect of a hypocaloric diet on adrenomedullin and natriuretic peptides in obese patients with essential hypertension.
J Minami, T Nishikimi, T Ishimitsu, Y Makino, Y Kawano, S Takishita, K Kangawa, H Matsuoka. J Cardiovasc Pharmacol 2000
30
11

Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.
J W Knowles, G Esposito, L Mao, J R Hagaman, J E Fox, O Smithies, H A Rockman, N Maeda. J Clin Invest 2001
232
11

Cardiac fibrosis in mice lacking brain natriuretic peptide.
N Tamura, Y Ogawa, H Chusho, K Nakamura, K Nakao, M Suda, M Kasahara, R Hashimoto, G Katsuura, M Mukoyama,[...]. Proc Natl Acad Sci U S A 2000
446
11

Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives.
P Dessì-Fulgheri, R Sarzani, M Serenelli, P Tamburrini, D Spagnolo, L Giantomassi, E Espinosa, A Rappelli. Hypertension 1999
56
11

The role of natriuretic peptides in cardioprotection.
Toshio Nishikimi, Nobuyo Maeda, Hiroaki Matsuoka. Cardiovasc Res 2006
349
11

Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes.
Coralie Sengenes, Anne Bouloumie, Hans Hauner, Michel Berlan, Rudi Busse, Max Lafontan, Jean Galitzky. J Biol Chem 2003
194
11


Salt-regulating hormones in young normotensive obese subjects. Effects of saline load.
G Licata, M Volpe, R Scaglione, S Rubattu. Hypertension 1994
74
11

Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells.
Cedric Moro, Jean Galitzky, Coralie Sengenes, François Crampes, Max Lafontan, Michel Berlan. J Pharmacol Exp Ther 2004
64
11

Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.
Cedric Moro, Francois Crampes, Coralie Sengenes, Isabelle De Glisezinski, Jean Galitzky, Claire Thalamas, Max Lafontan, Michel Berlan. FASEB J 2004
121
11


Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.
Marc S Sabatine, David A Morrow, James A de Lemos, C Michael Gibson, Sabina A Murphy, Nader Rifai, Carolyn McCabe, Elliott M Antman, Christopher P Cannon, Eugene Braunwald. Circulation 2002
550
11

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.
J A de Lemos, D A Morrow, J H Bentley, T Omland, M S Sabatine, C H McCabe, C Hall, C P Cannon, E Braunwald. N Engl J Med 2001
11


N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
Stefan K James, Bertil Lindahl, Agneta Siegbahn, Mats Stridsberg, Per Venge, Paul Armstrong, Elliot S Barnathan, Robert Califf, Eric J Topol, Maarten L Simoons,[...]. Circulation 2003
459
11

Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease.
David A Morrow, James A de Lemos, Michael A Blazing, Marc S Sabatine, Sabina A Murphy, Petr Jarolim, Harvey D White, Keith A A Fox, Robert M Califf, Eugene Braunwald. JAMA 2005
168
11


Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.
Lincoln R Potter, Andrea R Yoder, Darcy R Flora, Laura K Antos, Deborah M Dickey. Handb Exp Pharmacol 2009
344
11

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Monica M Colvin, Mark H Drazner, Gerasimos S Filippatos, Gregg C Fonarow, Michael M Givertz,[...]. J Card Fail 2017
392
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.